Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors

Current inhibitors of angiogenesis comprise either therapeutic antibodies (e.g. bevacicumab binding to VEGF-A) or small molecular inhibitors of receptor tyrosin kinases like e.g. sunitinib, which inhibits PDGFR and VEGFR. We have recently identified cyclin-dependent kinase 5 (Cdk5) as novel alternat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Weitensteiner, Sabine B., Liebl, Johanna, Krystof, Vladimir, Havlíček, Libor, Gucký, Tomáš, Strnad, Miroslav, Fürst, Robert, Vollmar, Angelika M., Zahler, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3545992/
https://ncbi.nlm.nih.gov/pubmed/23336010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054607
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados